Trial Profile
A Real-World Retrospective study to evaluate the safety and efficacy of Obinutuzumab-chlorambucil combination in elderly unfit Chronic Lymphocytic Leukemia patients with coexisting comorbidities
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2018
Price :
$35
*
At a glance
- Drugs Obinutuzumab (Primary) ; Chlorambucil
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 02 Jul 2018 New trial record
- 17 Jun 2018 Results presented at the 23rd Congress of the European Haematology Association
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology